Weitz & Luxenberg has achieved a $13.34 million judgment on a behalf of a victim who was viciously attacked at a bar in Queens, New…Read More
W&L Of Counsel Attorney Ellen Relkin to Participate in Three Legal Seminars in Three MonthsFeb. 8, 2017
Weitz & Luxenberg of counsel attorney Ellen Relkin will partake in three legal seminars — all within a three-month period.
Relkin’s first speaking engagement is slated for 9 a.m. Feb. 10, 2017, at The Westin Austin at The Domain, 11301 Domain Drive in Austin, Texas. The 45-minute discussion entitled Emerging Torts is part of the 2017 Texas Trial Lawyers Association Pharmaceutical & Medical Device Seminar.
The one-day mass tort workshop and seminar features some of the most seasoned and talented mass tort attorneys in the country. Attendees of this fourth annual event can earn continuing legal education credits.
Next, Relkin will moderate the Personal Jurisdiction Issues in Mass Torts panel at HB Litigation Conferences’ Mass Torts Judicial Forum on April 3, 2017, in New York City.
Weitz & Luxenberg of counsel attorney Robin L. Greenwald will also participate in the forum at The Roosevelt Hotel, 45 East 45 Street. Greenwald, who heads the Weitz & Luxenberg Environmental, Toxic Torts, and Consumer Protection Litigation group, will moderate a panel entitled Mass Torts & Criminality.
Then, on April 27, 2017, Relkin will serve as a co-chair of a day-long program devoted to Mass Torts at the New Jersey Association for Justice’s (NJAJ) Boardwalk Seminar 2017 at Harrah’s Resort in Atlantic City, New Jersey. Relkin will also speak on a panel discussing the Jurisprudential Legacy of the Honorable Carol Higbee.
The three-day NJAJ annual Boardwalk Meeting features top speakers from New Jersey and from around the nation. The gathering of prominent legal practitioners is designed to meet the continuing educational requirements of trial attorneys.
Relkin is a regular featured speaker at the Boardwalk Seminars, which are held annually. She served as a co-chair of Boardwalk Seminar 2016, during which she delivered a law update titled Mass Tort Plaintiffs’ and Defendants’ Perspectives.
At Weitz & Luxenberg, Relkin is co-chair of the Defective Drugs and Devices Practice Group, which focuses on medical device and pharmaceutical product liability, as well as toxic tort matters. Her experience serving in court-appointed leadership roles in major litigations makes her a sought-after speaker at continuing legal education programs nationally, the firm said.
Certified by the New Jersey Supreme Court as a Civil Trial Attorney, Relkin has represented thousands of plaintiffs injured by defective medical products with a recent focus on the generation of failed metal-on-metal and modular hip implants.
She is an elected member of the American Law Institute as well as the Summit Council. Relkin is an active member of the American Association for Justice; serves on the Board of Governors of the New Jersey Trial Lawyers Association; and is a member of the New Jersey, New York, and American Bar Associations.
Relkin has published law review articles in numerous legal publications and she has been consistently named as a “Super Lawyer” in both New York and New Jersey for the past several years. She has been AV rated by Martindale Hubble for more than two decades.